Pharmacokinetics of dexmedetomidine in anaesthetized horses following repeated subcutaneous administration and intravenous constant rate infusion

Bibliographic Details
Title: Pharmacokinetics of dexmedetomidine in anaesthetized horses following repeated subcutaneous administration and intravenous constant rate infusion
Authors: Federica Di Cesare, Vanessa Rabbogliatti, Susanna Draghi, Martina Amari, Federica Alessandra Brioschi, Roberto Villa, Giuliano Ravasio, Petra Cagnardi
Source: BMC Veterinary Research, Vol 19, Iss 1, Pp 1-9 (2023)
Publisher Information: BMC, 2023.
Publication Year: 2023
Collection: LCC:Veterinary medicine
Subject Terms: Balanced anaesthesia, Constant rate infusion, Dexmedetomidine, Equine patient, Liquid Chromatography Mass Spectrometry, Pharmacokinetics, Veterinary medicine, SF600-1100
More Details: Abstract Background The inclusion of dexmedetomidine (DEX) within a balanced general anaesthesia protocol is effective in improving the clinical outcome and recovery quality of anaesthesia in horses. This study aimed to determine the pharmacokinetic profile of DEX following repeated subcutaneous (SC) administration at 2 µg/kg every 60 min till the end of the procedure in comparison to intravenous constant rate infusion (CRI) at 1 µg/kg/h in anaesthetized horses undergoing diagnostic procedures up to the end of the diagnostic procedure. Results In the CRI and SC groups DEX maximum concentrations (Cmax) were 0.83 ± 0.27 ng/mL and 1.14 ± 0.71 ng/mL, respectively, reached at a time (Tmax) of 57.0 ± 13.4 min and 105.5 ± 29.9 min. Mean residence time to the last measurable concentration (MRTlast) was 11.7 ± 6.2 and 55.8 ± 19.7 min for the CRI group and SC groups, respectively. The apparent elimination half-life was 18.0 ± 10.0 min in the CRI group and 94.8 ± 69.8 min for the SC group, whereas the area under the curve (AUC0-last) resulted 67.7 ± 29.3 and 83.2 ± 60.5 min*ng/mL for CRI and SC group, respectively. Clearance was 16.26 ± 8.07 mL/min/kg for the CRI group. No signs of adverse effects were recorded in both groups. Conclusions The pharmacokinetic profile of DEX following repeated SC administration in anaesthetized horses was comparable to intravenous CRI administration during the intranaesthetic period and beneficial during the recovery phase from general anaesthesia. The SC route could be considered as an alternative to CRI for improving the recovery quality of equine patients undergoing general anaesthesia.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1746-6148
Relation: https://doaj.org/toc/1746-6148
DOI: 10.1186/s12917-023-03831-w
Access URL: https://doaj.org/article/e9f5dd171b1a444fb74e6c345e811c23
Accession Number: edsdoj.9f5dd171b1a444fb74e6c345e811c23
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:17466148
DOI:10.1186/s12917-023-03831-w
Published in:BMC Veterinary Research
Language:English